Invesco Dorsey Wright Healthcare Momentum ETF
Open-end / ETFRegistrant
Invesco Exchange-Traded Fund Trust
Class ticker
Net Assets
$235,211,770
Holdings
57
Latest Report
Jul 31, 2026
Net Assets Over Time
Holdings · 57
Export CSVSecurities-lending collateral: 2 rows, $64,988,486 (27.63% of net assets). The report marks these as cash received from borrowers of the fund's securities and reinvested, not as positions the fund chose.
Showing 1–50
of 57 holdings by value
· page 1 of 2
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
|
Invesco Private Prime Fund
Lending collateral
|
— | 48,906,882 | $48,911,773 | 20.79% | Long | STIV | |
|
Invesco Private Government Fund
Lending collateral
|
— | 16,076,714 | $16,076,714 | 6.83% | Long | STIV | |
| Guardant Health, Inc. | GH | 72,199 | $11,695,516 | 4.97% | Long | EC | |
| Roivant Sciences Ltd. | ROIV | 343,019 | $11,631,774 | 4.95% | Long | EC | |
| Revolution Medicines, Inc. | RVMD | 61,927 | $11,613,170 | 4.94% | Long | EC | |
| Axsome Therapeutics, Inc. | AXSM | 44,490 | $9,698,375 | 4.12% | Long | EC | |
| BrightSpring Health Services, Inc. | BTSG | 158,696 | $9,475,738 | 4.03% | Long | EC | |
| Liquidia Corp. | LQDA | 84,234 | $7,084,922 | 3.01% | Long | EC | |
| Erasca, Inc. | ERAS | 381,019 | $6,915,495 | 2.94% | Long | EC | |
| Oruka Therapeutics, Inc. | ORKA | 66,716 | $6,438,761 | 2.74% | Long | EC | |
| 10x Genomics, Inc. | TXG | 112,984 | $5,340,754 | 2.27% | Long | EC | |
| Relay Therapeutics, Inc. | RLAY | 280,758 | $5,286,673 | 2.25% | Long | EC | |
| Tango Therapeutics Inc. | TNGX | 186,706 | $5,074,669 | 2.16% | Long | EC | |
| Travere Therapeutics, Inc. | TVTX | 90,742 | $5,071,570 | 2.16% | Long | EC | |
| Oscar Health, Inc. | OSCR | 158,058 | $4,934,571 | 2.10% | Long | EC | |
| Illumina, Inc. | ILMN | 23,863 | $4,894,301 | 2.08% | Long | EC | |
| agilon health, Inc. | AGL | 53,027 | $4,857,803 | 2.07% | Long | EC | |
| Axogen, Inc. | AXGN | 114,692 | $4,841,149 | 2.06% | Long | EC | |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 55,978 | $4,738,538 | 2.01% | Long | EC | |
| Spyre Therapeutics, Inc. | SYRE | 48,127 | $4,732,328 | 2.01% | Long | EC | |
| Replimune Group, Inc. | REPL | 405,048 | $4,536,538 | 1.93% | Long | EC | |
| Jazz Pharmaceuticals PLC | JAZZ | 17,925 | $4,532,516 | 1.93% | Long | EC | |
| Moderna, Inc. | MRNA | 81,355 | $4,459,881 | 1.90% | Long | EC | |
| Cytokinetics, Inc. | CYTK | 57,568 | $4,440,220 | 1.89% | Long | EC | |
| Viatris Inc. | VTRS | 243,859 | $4,282,164 | 1.82% | Long | EC | |
| Centene Corp. | CNC | 67,565 | $4,203,894 | 1.79% | Long | EC | |
| Humana Inc. | HUM | 11,434 | $4,160,375 | 1.77% | Long | EC | |
| Ligand Pharmaceuticals Inc. | LGND | 14,247 | $4,096,582 | 1.74% | Long | EC | |
| Corcept Therapeutics Inc. | CORT | 35,225 | $4,032,910 | 1.71% | Long | EC | |
| Enliven Therapeutics, Inc. | ELVN | 72,884 | $3,994,772 | 1.70% | Long | EC | |
| Twist Bioscience Corp. | TWST | 40,860 | $3,740,733 | 1.59% | Long | EC | |
| Hims & Hers Health, Inc. | HIMS | 133,217 | $3,699,436 | 1.57% | Long | EC | |
| MBX Biosciences, Inc. | MBX | 54,646 | $3,602,811 | 1.53% | Long | EC | |
| Arcutis Biotherapeutics, Inc. | ARQT | 133,630 | $3,589,302 | 1.53% | Long | EC | |
| Establishment Labs Holdings Inc. | ESTA | 38,410 | $3,554,461 | 1.51% | Long | EC | |
| uniQure N.V. | QURE | 81,027 | $3,535,208 | 1.50% | Long | EC | |
| PACS Group, Inc. | PACS | 68,052 | $3,131,073 | 1.33% | Long | EC | |
| Exelixis, Inc. | EXEL | 58,311 | $3,092,232 | 1.31% | Long | EC | |
| Trevi Therapeutics, Inc. | TRVI | 150,679 | $2,749,892 | 1.17% | Long | EC | |
| Krystal Biotech, Inc. | KRYS | 8,055 | $2,747,722 | 1.17% | Long | EC | |
| National HealthCare Corp. | NHC | 11,635 | $2,629,859 | 1.12% | Long | EC | |
| Amneal Pharmaceuticals, Inc. | AMRX | 143,351 | $2,626,190 | 1.12% | Long | EC | |
| Alkermes PLC | ALKS | 52,682 | $2,580,891 | 1.10% | Long | EC | |
| Veracyte, Inc. | VCYT | 55,185 | $2,556,169 | 1.09% | Long | EC | |
| NeoGenomics, Inc. | NEO | 165,576 | $2,531,657 | 1.08% | Long | EC | |
| Nuvation Bio Inc. | NUVB | 394,869 | $2,499,521 | 1.06% | Long | EC | |
| TG Therapeutics, Inc. | TGTX | 47,707 | $2,482,195 | 1.06% | Long | EC | |
| AbSci Corp. | ABSI | 300,499 | $2,337,882 | 0.99% | Long | EC | |
| Denali Therapeutics Inc. | DNLI | 99,311 | $2,286,139 | 0.97% | Long | EC | |
| Disc Medicine, Inc. | IRON | 27,202 | $2,094,554 | 0.89% | Long | EC |
Showing the top 50 of 57 holdings. Create a free account to see every holding and download the CSV.